mw. dr. E.J.M. Siemerink

Overige informatie

Aandachtsgebieden

Nevenfuncties

BIG-nummer

Wetenschappelijke publicaties en onderzoeken

• Limited Impact of Breast Cancer and Non-breast Malignancies on Survival in Older Patients with Early-Stage Breast Cancer: Results of a Large, Single-Centre, Population-Based Study

  Jobsen JJ, Palen J van der, Siemerink EJM, Struikmans H.
  Clin Oncol (R Coll Radiol). 2022; 34(6):355-362.
  

• The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer

  Jobsen JJ, Struikmans H, Palen JJ van der , Siemerink EJM.
  Breast Cancer Res Treat. 2020; 181(1):13-21.
  

• Breast-conserving therapy in older patients with breast cancer over three decades: progress or stagnation.

  Jobsen JJ, Middelburg JG, Palen J van der , Riemersma S, Siemerink EJM, Struikmans H, Siesling S.
  J Geriatr Oncol. 2018; :doi: 10.1016/j.jgo.2018.08.007. [Epub ahead of print].
  Publicatie openen

• Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency

  Henricks LM, Siemerink EJM, Rosing H, Meijer J, Goorden SM, Polstra AM, Zoetekouw L, Cats A, .
  Int J Cancer. 2018; 142(2):424-430.
  

• Preoperative chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study

  Trip AK, Poppema BJ, Berge Henegouwen MI van, Siemerink EJM, Beukema JC, Verheij M, Plukker JT, Richel DJ, Hulshof MC, Sandick JW van, Cats A, Jansen EP, Hospers .
  Radiother Oncol 2014; 112(2):284-8.
  Publicatie openen